IN VIVO EVALUATION OF LONG-ACTING BIODEGRADABLE EMTRICITABINE IMPLANTS
Long-acting (LA) antiretroviral interventions hold promise to revolutionise HIV therapy and prevention and mitigate key concerns regarding adherence to oral medications. The current study investigated a biodegradable subcutaneous implant derived from a polymer formed entirely from an emtricitabine (FTC) prodrug (POP implant). For in vitro studies, POP implants were incubated in 1 mL of phosphate…